Touchlight Genetics announced as Best Emerging UK Synthetic Biotech Company at OBN Awards 2016
- Posted on 7 October, 2016
SynbiCITE congratulates Touchlight Genetics as the winner of Best Emerging UK Synthetic Biotech Company at the OBN’s 8th Annual Awards Ceremony held last night. The OBN Awards celebrate innovation and achievement across the UK life sciences industry, including emerging to late stage R&D companies as well as life science investors.
Touchlight Genetics, a London-based biotechnology company, has successfully established and patented a revolutionary enzymatic process of DNA amplification. Their success at the OBN Awards was attributed to the development of an innovative, in vitro dual enzyme process, capable of producing DNA at commercial scale and quality.
In sponsoring this award, we are supporting the growth of the UK’s burgeoning synthetic biology industry, a core aim of SynbiCITE.
The 3 finalist companies under consideration for this award were:
- Chain Biotech
- Green Biologics
- Touchlight Genetics
Share this article:
People also read
Book before March 29th to receive 20% discount*
Building a multibillion-dollar synthetic biology industry The Synthetic Biology conference taking place in 2019, in London, that is not to be missed....
Evonetix establishes scientific advisory board
CAMBRIDGE, UK, 20 December 2018 – EVONETIX LTD (‘Evonetix’), the Cambridge-based company pioneering an innovative approach to scalable and high-fideli...
Synthetic biology start-up Colorifix raises $3m Series A round to scale its revolutionary textile dyeing solution
Colorifix, a company that has developed the first commercial biological dyeing process, has raised a Series A round of $3 million from impact and stra...